Shahandeh, A.; Johnstone, D.M.; Atkins, J.R.; Sontag, J.-M.; Heidari, M.; Daneshi, N.; Freeman-Acquah, E.; Milward, E.A.
Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing. Microarrays 2016, 5, 12.
https://doi.org/10.3390/microarrays5020012
AMA Style
Shahandeh A, Johnstone DM, Atkins JR, Sontag J-M, Heidari M, Daneshi N, Freeman-Acquah E, Milward EA.
Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing. Microarrays. 2016; 5(2):12.
https://doi.org/10.3390/microarrays5020012
Chicago/Turabian Style
Shahandeh, Al, Daniel M. Johnstone, Joshua R. Atkins, Jean-Marie Sontag, Moones Heidari, Nilofar Daneshi, Elvis Freeman-Acquah, and Elizabeth A. Milward.
2016. "Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing" Microarrays 5, no. 2: 12.
https://doi.org/10.3390/microarrays5020012
APA Style
Shahandeh, A., Johnstone, D. M., Atkins, J. R., Sontag, J.-M., Heidari, M., Daneshi, N., Freeman-Acquah, E., & Milward, E. A.
(2016). Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing. Microarrays, 5(2), 12.
https://doi.org/10.3390/microarrays5020012